Northrop Grumman Corporation (NYSE: NOC) will highlight its experience enabling drug development for federal and commercial programs at the 43rd Drug Information Association (DIA) Annual Meeting.
The conference and exposition will be held June 17-21 at the Georgia World Congress Center in Atlanta. Northrop Grumman will exhibit at booth 427.
At its booth, Northrop Grumman will showcase its experience in electronic health record systems, the Medical Dictionary for Regulatory Activities (MedDRA), clinical trials management, complete IT systems interoperability and connectivity, and the pharmacological science of detecting, assessing and preventing long- and short-term side effects of medicine.
The company will demonstrate the largest globally deployed, patient-centric electronic health record system, AHLTA. AHLTA is the U.S. Department of Defense’s interoperable healthcare information system serving more than nine million beneficiaries. The AHLTA demonstration exhibits the granularity of captured computable data, ease of use of a structured vocabulary, and the ability to rapidly tailor the type of data captured during a patient encounter to account for multiple diagnoses and provide accurate, automatic coding of the encounter. AHLTA data can be a critical source for the safe and effective profiling of post-marketed drugs.